Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
about
Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment ChoicesTreatment strategies for multiple sclerosis: When to start, when to change, when to stop?Human Adipose Stromal/Stem Cells from Obese Donors Show Reduced Efficacy in Halting Disease Progression in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.Effectiveness of glatiramer acetate compared to other multiple sclerosis therapiesDifferential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon.Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.Guideline for multiple sclerosis treatment in Brazil: Consensus from the Neuroimmunology Scientific Department of the Brazilian Academy of Neurology.MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b.Flow cytometric analysis of T cell/monocyte ratio in clinically isolated syndrome identifies patients at risk of rapid disease progression.
P2860
Q26748229-11CA3538-9106-4D11-B416-90C72E76FA89Q26798434-106ADC74-0291-465D-A64B-68BD215C6727Q30731580-DDCB5580-9DB1-4874-8E03-C4EBABE72B11Q35743570-2C8D2422-4458-44C8-A37E-D0A34BE9689BQ35749670-5DF7F673-B2EF-40EA-B30B-533BBB57AB57Q36202727-775A0D62-5E36-451A-BBA2-E1D58711BCE2Q39093778-6412B864-EC53-41A6-8792-01C6E3F93ABEQ39544816-241E1222-032E-4191-BECA-46FA7334E1C0Q40749805-0F9B577A-5BC8-45C9-AFD4-98960E2E0DAA
P2860
Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
@ast
Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
@en
Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
@en-gb
Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
@nl
type
label
Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
@ast
Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
@en
Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
@en-gb
Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
@nl
prefLabel
Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
@ast
Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
@en
Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
@en-gb
Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
@nl
P2093
P2860
P50
P3181
P1476
Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
@en
P2093
Alberto Vaona
Anna Gandini
Anna Longobardi
Francesco Berardo
Giulio Rigon
Marco Rovaris
Serena Frau
P2860
P3181
P356
10.1002/14651858.CD009333.PUB2
P577
2014-07-26T00:00:00Z